Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-087475
Filing Date
2021-03-19
Accepted
2021-03-19 16:06:33
Documents
4
Effectiveness Date
2021-03-19

Document Format Files

Seq Description Document Type Size
1 S-8 d152190ds8.htm S-8 53883
2 EX-5.1 d152190dex51.htm EX-5.1 10218
3 EX-23.2 d152190dex232.htm EX-23.2 1340
4 GRAPHIC g152190dsp7.jpg GRAPHIC 2705
  Complete submission text file 0001193125-21-087475.txt   70373
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254499 | Film No.: 21758222
SIC: 2834 Pharmaceutical Preparations